The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Epirubicin 2 mg/ml Solution for Injection



Seacross Pharma (Europe) LimitedPA22766/003/001

Main Information

Trade NameEpirubicin 2 mg/ml Solution for Injection
Active SubstancesEpirubicin hydrochloride
Dosage FormSolution for injection
Licence HolderSeacross Pharma (Europe) Limited
Licence NumberPA22766/003/001

Group Information

ATC CodeL01DB Anthracyclines and related substances
L01DB03 epirubicin

Status

License statusAuthorised
Licence Issued03/04/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back